- CONTACT US
- AFS
- Business
- Bussiness
- Car
- Career
- Celebrity
- Digital Products
- Education
- Entertainment
- Fashion
- Film
- Food
- Fun
- Games
- General Health
- Health
- Health Awareness
- Healthy
- Healthy Lifestyle
- History Facts
- Household Appliances
- Internet
- Investment
- Law
- Lifestyle
- Loans&Mortgages
- Luxury Life Style
- movie
- Music
- Nature
- News
- Opinion
- Pet
- Plant
- Politics
- Recommends
- Science
- Self-care
- services
- Smart Phone
- Sports
- Style
- Technology
- tire
- Travel
- US
- World
Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
I spent the last year transforming my life. Becoming a Rockette for a day made me confront a fear I couldn't shake. - 2Several Israelis attempt to cross into Gaza, escorted back to Israel by IDF
- 380 km. on foot: Sharren Haskel’s three-day march in protest of haredi draft bill
- 4NASA says Maven spacecraft that was orbiting Mars has gone silent
- 5Netflix is releasing a documentary on Elizabeth Smart. What to know about her kidnapping, rescue and where she is now.
- Novo Nordisk slashes prices of popular weight loss and diabetes drugs
- US FDA panel to weigh bid to market nicotine pouches as lower-risk than cigarettes
- Abbott issues US device correction for some glucose monitors over faulty readings risk
- Doritos and Cheetos dial back the bright orange in new versions without artificial ingredients
- Amazon sued over 'punitive' handling of employee absences
- When does Spotify Wrapped come out? The music streamer says 'soon.'
- Europe's powerful Ariane 6 rocket launches Sentinel-1D Earth-observation satellite to orbit (video)
- Novo Nordisk gears up for December Ozempic launch in India, sources say
- Eli Lilly to build $6 billion Alabama plant as part of US manufacturing push
